Single-center multidisciplinary management of patients with colorectal cancer and resectable synchronous liver metastases improves outcomes

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 1, 2013, Pages 47-55

  Goyer, Perrine ^a   Karoui, Mehdi ^a   Vigano, Luca ^a   Kluger, Michael ^b   Luciani, Alain ^a   Laurent, Alexis ^a   Azoulay, Daniel ^a   Cherqui, Daniel ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIMARY TUMOR; RESECTABLE SYNCHRONOUS LIVER METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PATIENT CARE TEAM; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84873131009     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.03.003     Document Type: Article

References (41)

1. Manfredi S., Lepage C., Hatem C., et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 2006, 244:254-259.
2. Simmonds P.C., Primrose J.N., Colquitt J.L., et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006, 94:982-999.
3. Nordlinger B., Van Cutsem E., Gruenberger T., et al. European colorectal metastases treatment group; sixth international colorectal liver metastases workshop. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 2009, 20:985-992.
4. Adam R. Colorectal cancer with synchronous liver metastases. Br J Surg 2007, 94:129-131.
5. Reddy S.K., Barbas A.S., Clary B.M. Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management?. Ann Surg Oncol 2009, 16:2395-2410.
6. Hillings J.G., Wille-Jorgensen P Staged or simultaneous resection of synchronous liver metastases from colorectal cancer: a systematic review. Colorectal Dis 2009, 11:3-10.
7. Chen J., Li Q., Wang C., et al. Simultaneous vs. staged resection for synchronous colorectal liver metastases: a metaanalysis. Int J Colorectal Dis 2011, 26:191-199.
8. Zalinski S., Mariette C., Farges O. Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version. J Visc Surg 2011, 148(3):e171-182. SFCD-ACHBT evaluation committee.
9. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999, 230:309-318.
10. Adam R., Pascal G., Castaing D., et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann Surg 2004, 240:1052-1061.
11. Garden O.J., Rees M., Poston G.J., Mirza, et al. Guidelines for resection of colorectal cancer liver metastases. Gut 2006, 55(3):iii1-iii8.
12. Ksienski D., Woods R., Speers C., Kennecke H Patterns of referral and resection among patients with liver-only metastatic colorectal cancer (MCRC). Ann Surg Oncol 2010, 17:3085-3093.
13. Karoui M., Soprani A., Charachon A., et al. Primary chemotherapy with or without colonic stent for management of irresectable stage IV colorectal cancer. Eur J Surg Oncol 2010, 36:58-64.
14. Karoui M., Vigano L., Goyer P., et al. Combined first stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases. Br J Surg 2010, 97:1354-1362.
15. Slim K., Blay J.Y., Brouquet A., et al. Digestive oncology: surgical practices. J Chir (Paris) 2009, 146(Suppl 2):S11-S80.
16. Cherqui D., Malassagne B., Colau P.I., et al. Hepatic vascular exclusion with preservation of the caval flow for liver resections. Ann Surg 1999, 230:24-30.
17. Chouillard E., Cherqui D., Tayar C., et al. Anatomical bi- and trisegmentectomies as alternatives to extensive liver resections. Ann Surg 2003, 238:29-34.
18. Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004, 240:205-213.
19. Balzan S., Belghiti J., Farges O., et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005, 242:824-828.
20. Lazorthes F., Navarro F., Ychou M., et al. ANAES. Therapeutic management of hepatic metastases from colorectal cancers. Gastroenterol Clin Biol 2003, 27(No 2):B7.
21. Tanaka K., Adam R., Shimada H., et al. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003, 90:963-969.
22. Gruenberger B., Scheithauer W., Punzengruber R., et al. Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. BMC Cancer 2008, 8:120.
23. Viganò L., Ferrero A., Lo Tesoriere R., et al. Liver surgery for colorectal metastases: results after 10years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 2008, 15:2458-2464.
24. Allen P.J., Kemeny N., Jarnagin W., et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003, 7:109-115.
25. Eisenberger A., Whelan R.L., Neugut A.I. Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review. Int J Colorectal Dis 2008, 23:559-568.
26. Scheer M.G., Sloots C.E., van der Wilt G.J., et al. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 2008, 19:1829-1835.
27. Poultsides G., Servais E., Saltz L., et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 2009, 27:3379-3384.
28. Karoui M., Koubaa W., Delbaldo C., et al. Chemotherapy has also an effect on primary tumor in colon carcinoma. Ann Surg Oncol 2008, 15:3440-3446.
29. Sebastian S., Johnston S., Geoghegan T., et al. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004, 99:2051-2057.
30. Karoui M., Charachon A., Delbaldo C., et al. Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration. Arch Surg 2007, 142:619-623.
31. Karoui M., Penna C., Amin-Hashem M., et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006, 243:1-7.
32. Zorzi D., Laurent A., Pawlik T.M., et al. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007, 94:274-286.
33. Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC InterGroup trial 40983): a randomised controlled trial. Lancet 2008, 371:1007-1016.
34. Benoist S., Brouquet A., Penna C., et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?. J Clin Oncol 2006, 24:3939-3945.
35. Brouquet A., Mortenson M.M., Vauthey J.N., et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?. J Am Coll Surg 2010, 210:934-941.
36. Chiesser M., Chen J.W., Maddern G.J., et al. Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases. J Gastrointest Surg 2008, 12:1054-1060.
37. Ito H., Are C., Gonen M., et al. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008, 247:994-1002.
38. Capussotti L., Ferrero A., Viganò L., et al. Major liver resections synchronous with colorectal surgery. Ann Surg Oncol 2007, 14:195-201.
39. Reddy S.K., Pawlik T.M., Zorzi D., et al. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 2007, 14:3481-3491.
40. Thelen A., Jonas S., Benckert C., et al. Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis 2007, 22:1269-1276.
41. de Haas R.J., Wicherts D.A., Flores E., et al. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?. Ann Surg 2008, 248:626-637.